GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)
India flag India · Delayed Price · Currency is INR
2,880.00
+43.10 (1.52%)
Mar 28, 2025, 3:30 PM IST

NSE:GLAXO Statistics

Total Valuation

NSE:GLAXO has a market cap or net worth of INR 487.43 billion. The enterprise value is 466.47 billion.

Market Cap 487.43B
Enterprise Value 466.47B

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025.

Earnings Date May 13, 2025
Ex-Dividend Date Nov 7, 2024

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +0.03%
Shares Change (QoQ) -1.58%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 41.29M

Valuation Ratios

The trailing PE ratio is 56.73.

PE Ratio 56.73
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio 29.46
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 54.29
EV / Sales 12.59
EV / EBITDA 42.73
EV / EBIT 45.23
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.01
Debt / EBITDA 0.01
Debt / FCF n/a
Interest Coverage 688.10

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 39.68%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 11.54M
Profits Per Employee 2.68M
Employee Count 3,211
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +53.21% in the last 52 weeks. The beta is 0.17, so NSE:GLAXO's price volatility has been lower than the market average.

Beta (5Y) 0.17
52-Week Price Change +53.21%
50-Day Moving Average 2,407.50
200-Day Moving Average 2,545.49
Relative Strength Index (RSI) 65.45
Average Volume (20 Days) 160,653

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NSE:GLAXO had revenue of INR 37.05 billion and earned 8.59 billion in profits. Earnings per share was 50.71.

Revenue 37.05B
Gross Profit 22.78B
Operating Income 10.31B
Pretax Income 11.72B
Net Income 8.59B
EBITDA 10.74B
EBIT 10.31B
Earnings Per Share (EPS) 50.71
Full Income Statement

Balance Sheet

The company has 21.11 billion in cash and 147.90 million in debt, giving a net cash position of 20.96 billion.

Cash & Cash Equivalents 21.11B
Total Debt 147.90M
Net Cash 20.96B
Net Cash Per Share n/a
Equity (Book Value) 16.73B
Book Value Per Share 97.18
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 61.49%, with operating and profit margins of 27.84% and 23.19%.

Gross Margin 61.49%
Operating Margin 27.84%
Pretax Margin 31.63%
Profit Margin 23.19%
EBITDA Margin 28.99%
EBIT Margin 27.84%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 44.00, which amounts to a dividend yield of 1.53%.

Dividend Per Share 44.00
Dividend Yield 1.53%
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield -0.03%
Shareholder Yield 1.49%
Earnings Yield 1.76%
FCF Yield n/a
Dividend Details

Stock Splits

The last stock split was on September 11, 2018. It was a forward split with a ratio of 2.

Last Split Date Sep 11, 2018
Split Type Forward
Split Ratio 2

Scores

Altman Z-Score n/a
Piotroski F-Score n/a